SkinBioTherapeutics is a life sciences company focused on advancing skin health across wellbeing, repair and beauty.
Our core focus is translating evidence-based science into products and intellectual property that could make a real difference to people’s skin. Our portfolio spans topical ingredients, oral supplements, intellectual property for outlicensing, and in-house services and manufacturing.
SkinBioTherapeutics plc is listed on the AIM market of the London Stock Exchange under the ticker SBTX.